Case for diagnosis. Stewart-Treves syndrome after mastectomy^☆

Case report

A 56-year-old female patient reported the appearance of a nodule on the posterior region of the right arm six months before. During this period, she reported that the lesion showed progressive growth, pain, and friability, with frequent local bleeding. This patient had been submitted to a radical mastectomy and right axillary dissection, with adjuvant chemotherapy and radiotherapy 11 years before, and since then, she had chronic lymphedema in the right upper limb.

Dermatological examination revealed a hyperchromic tumor, measuring approximately 5.0 × 4.0 cm, with central areas of ulceration and slight local bleeding on the posterior region of the right arm. Lymphedema was also observed in the right upper limb and violaceous-brown satellite nodules, measuring up to 0.5cm (Fig. 1).

Figure 1
(A), Lymphedema in the right upper limb. (B), Tumor with ulcerated areas in the posterior region of the right arm, accompanied by satellite nodules.

An incisional biopsy of the tumor and satellite nodules was performed. The patient returned for consultation after one month with a histopathological result that showed a neoplasm characterized by vascular formations permeated by atypical epithelioid cells infiltrating the superficial and deep dermis, with perineural permeation (Fig. 2).

Figure 2
Proliferation of epithelioid and spindle cells, permeating malformed vascular channels and spaces, (Hematoxylin & eosin, ×100).

At this consultation the tumor was slightly larger and there was an increase in the number of satellite lesions (Fig. 3).

Figure 3
Significant increase in the number of satellite lesions and in the ulcerated area of the central tumor.

What is your diagnosis?

• a) Stewart-Treves syndrome

• b) Squamous cell carcinoma

• c) Melanoma

• d) Merkel carcinoma

Immunohistochemistry examination was requested, which showed CD31 positivity, confirming the hypothesis of Stewart-Treves syndrome (Fig. 4).

Figure 4
Immunohistochemistry showing positivity for CD31.

Discussion

Stewart-Treves syndrome (STS) is a rare entity, with a poor prognosis, consisting of the appearance of cutaneous angiosarcoma in areas of chronic lymphedema and accounts for approximately 5% of angiosarcomas.¹,²,³,⁴ Its occurrence is more commonly observed after a radical mastectomy with axillary dissection, with a latency period that varies from five to 11 years.²,⁴ However, it can also appear in areas of chronic lymphedema due to venous stasis, morbid obesity, post-surgical procedures, lymphatic malformations, and chronic infections, among others.²,⁵

The etiology and pathophysiology of the syndrome remain unknown. It is debated whether the lymphedema would favor oncogenesis due to the lymphatic drainage failure and interstitial fluid accumulation and stasis, in addition to the possible occurrence of neoplastic transformation during angiogenesis.⁴ They initially present as macules and papules, developing into nodules and tumors that can reach large volumes.⁶,⁷ Satellite lesions, pain, and local bleeding are common.⁶

The diagnosis is based on the clinical picture, along with the biopsy. Histopathology may be suggestive, with irregular vascular spaces lined by mitotic hyperchromatic pleomorphic tumor endothelial cells.⁴ Immunohistochemistry helps in the diagnostic confirmation, with both CD31 and CD34 markers being positive.⁴

The treatment is based on surgical resection with wide margins, and chemotherapy and radiotherapy can also be used.²,³,⁶,⁷ In the present case, the oncology service chose to use chemotherapy with docetaxel, and the oncology surgery team, so far has not indicated surgical treatment. The occurrence of distant metastases is not uncommon,³ with the lungs being the most commonly affected organs; the patient in the present case was submitted to CT scans of the chest, abdomen, and pelvis, which did not disclose the presence of metastases.

Although it is rare, knowledge of STS is necessary because, due to its aggressiveness, only its early diagnosis can help to increase patient survival.

• Financial support
  None declared.
• ☆
  Study conducted at the Department of Dermatology, Faculdade de Medicina de Jundiaí, Jundiaí, SP, Brazil.

References

• ¹
  Wang LL, Cui LF, Gao Y, Jiang ZC. Clinicopathologic features of Stewart-Treves syndrome. Int J Clin Exp Pathol. 2019;12:680–8.
• ²
  Sharma A, Schwartz RA. Stewart-Treves syndrome: pathogenesis and management. J Am Acad Dermatol. 2012;67:1342–8.
• ³
  Degrieck B, Crevits I. Cutaneous angiosarcoma postmastectomy (Stewart-Treves Syndrome). J Belg Soc Radiol. 2018;102:60.
• ⁴
  Murgia RD, Gross GP. Stewart-Treves syndrome [publicação na web]. In: StatPearls. Treasure Island (FL): Statpearls publishing; 2020. Accessed 12 August 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507833/
  » https://www.ncbi.nlm.nih.gov/books/NBK507833/
• ⁵
  Benmansour A, Laanaz S, Bougtab A. Stewart–Treves syndrome: a case report. PAMJ One Health. 2014;19:2.
• ⁶
  Pereira ESP, Moraes ET, Siqueira DM, Santos MAS. Síndrome de Stewart-Treves. An Bras Dermatol. 2015;90:226–8.
• ⁷
  Veiga RRG, Nascimento BAM, Carvalho AH, Brito AC, Bittencourt MJS. Síndrome de Stewart-Treves no membro inferior. An Bras Dermatol. 2015;90:229–31.

Publication Dates

• Publication in this collection
  30 Sept 2022
• Date of issue
  Sep-Oct 2022

History

• Received
  14 Oct 2021
• Accepted
  14 Dec 2021
• Published
  08 July 2022